Patent 8460173 was granted and assigned to Edwards Lifesciences on June, 2013 by the United States Patent and Trademark Office.
Devices and methods for treatment of a failing heart by reducing the heart wall stress. The device can be one which reduces wall stress throughout the cardiac cycle or only a portion of the cardiac cycle.